期刊文献+

急性心肌梗死急诊介入治疗无复流的研究进展 被引量:5

Research progress for no-reflow in patients with acute myocardial infarction after emergency percutaneous coronary intervention
下载PDF
导出
摘要 无复流是指急性心肌梗死心外膜冠状动脉再通后,心肌组织水平的再灌注不完全,甚至无再灌注的现象;无复流使急性心肌梗死患者死亡率明显增加。本文对无复流的发生机制、诊断和治疗方法作一综述。 No-reflow phenomenon is incomplete reperfusion dial coronary recanalization in acute myocardial infarction in AMI patients. The present article reviewed mechanism, or even no reperfusion in myocardial tissue after epicar-(AMI); no-reflow significantly increases mortality rate diagnosis and therapeutic methods for no-reflow.
出处 《心血管康复医学杂志》 CAS 2013年第5期525-527,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
  • 相关文献

参考文献13

  • 1Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory [J]. Catheter Cardiovase Interv, 2008, 72 (7): 950-957.
  • 2Nieeoli G, Cosentino N, Spaziani C, et al. New strategies for the management of no-reflow after primary percutaneous coro- nary intervention [J]. Expert Rev Cardiovasc Ther, 2011, 9 (5): 615-630.
  • 3Okamura A, Ito H, Iwakura K, et al. Detection of embolic parti- cles with the Doppler guide wire during coronary intervention in patients with. acute myocardial infarction: efficacy of distal pro- tectiondeviee [J]. J Am Coil Cardiol, 2005, 45 (2): 212-215.
  • 4Yip HK, Chen MC, Chang HW, et al. Angiographic morpholog- ic features of infarct-related arteries and timely reperfusion in a- cute myocardial infarction: predictors of stow-flow and no-reflow phenomenon [J]. Chest, 2002, 122 (4): 1322-1332.
  • 5Matsumoto H, Inoue N, Takaoka H, et al. Depletion of antioxi- dants is associated with no-reflow phenomenon in acute myocar- dial infarction. [J]. Clin Cardiol, 2004, 27 (8): 466-470.
  • 6Zhao J, Yang Y, You S, et al. Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardi- al infarction and reperfusion [J]. Int J Cardiol, 2007, 115 (3): 334-341.
  • 7Thiele H, Schindler K, Friedenberger J, et al. Intracoronary compared with intravenous bolus abciximab application in pa- tients with ST-elevation myocardial infarction undergoing prima- ry percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximah IV ver- sus IC in ST-elevation myocardial infarction trial [J]. Circula- tion, 2008, 118 (I): 49-57.
  • 8Ross AM, Gibbons RJ, Stone GW, et al. A randominzed, double-blinded, placebo contolled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMLSTADII) [J]. J Am Coll Cardiot, 2005, 45 (11): 1775-1780.
  • 9Hayashi M, Tsutamoto T, Wada A, et al. Administration of at- rial natriuretic peptide prevents left ventricular remodeling in pa- tients with first anterior acute myocardial infarction [J]. J Am Coll Cardiol, 2001, 37 (7): 1820-1826.
  • 10Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for a- cute myocardial infarction (J-WIND): two randomised trials [J]. Lancet, 2007, 370 (9597): 1483-1493.

同被引文献32

  • 1孙菁,沈洪.急性心肌梗死患者冠状动脉再通后无复流相关因素的分析[J].中国全科医学,2009,12(7):551-553. 被引量:20
  • 2VRACHATIS A D, ALPERT M A, GEORGULAS V P, et al. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count [J]. Angiology, 2001, 52(3): 161-166.
  • 3MORITA E, YASUE H, YOSHIMURA M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction [ J ]. Circulation, 1993, 88 ( 1 ) : 82-91.
  • 4ARAKAWA N, NAKAMURA M, AOKI H, et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size [Jl. Cardiology, 1994, 85 (5) : 334- 340.
  • 5KRISHNA A, KAPOOR A, KUMAR S, et al. Elevated B- Type natriuretic peptide levels in patients undergoing coronary stenting[ J ]. J Invasive Cardiol, 2011, 23 (6) : 240-245.
  • 6Bae JH,Kwon TG,Hyun DW,et al.Predictors of slow flow during primary percutaneous coronary intervention:an intravascular ultrasound-virtual histology study[J].Heart,2008,94(12):1559-1564.
  • 7Vrachatis AD,Alpert MA,Georgulas VP,et al.Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction:quantitative assessment using the corrected TIMI frame count[J].Angiology,2001,52(3):161-616.
  • 8Kirma C,Izgi A,Dundar C,et al.Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions:experience at a single center[J].Circ J,2008,72(5):716-721.
  • 9Yip HK,Chen MC,Chang HW,et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction:predictors of slow-flow and no-reflow phenomenon[J].Chest,2002,122(4):1322-1332.
  • 10Ueshima S,Matsuo O.Development of new fibrinolytic agents[J].Curr Pharm Des,2006,12(7):849-857.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部